Navigation Links
The Answer To Prevent Osteoporosis

A pill a day could be the answer for building bone as you age. A new study shows the drug alendronate taken daily for 10 years increases // bone density in postmenopausal women.Osteoporosis is a chronic, progressive disorder where there is a loss of normal bone density. Drugs, such as alendronate, have been used for years to treat osteoporosis. The current research is the result of following patients taking alendronate for up to a decade.

The research began with a three-year study on women taking the drug or a placebo. Women on the drug continued to receive the drug for the next two years. Then for the next five years, women on 5 milligrams or 10 milligrams of the drug continued with the drug at the same dose, while another group of women received 20 milligrams of the drug for two years. That was followed by 5 milligrams of the drug for three years and then a placebo for the next five years. Researchers say 247 women stayed with the study for the entire 10 years.

The study showed women on 10 milligrams of alendronate daily increased their bone density compared to women not on the drug. Women on 5 milligrams had smaller gains than women on 10 milligrams. In addition, researchers say women who were on the drug and then taken off of it had a gradual loss of their improvements in their bone density.

Researchers say continuous treatment of 10 milligrams of alendronate appears to be the best treatment for postmenopausal women and the key is staying on the drug because once you go off of it the benefits start to diminish.
'"/>




Page: 1

Related medicine news :

1. Answer on SARS 3 to 4 weeks away
2. Answers For OCD soon
3. Neurobiology Provides Answers To Block Memory-Related Drug Cravings
4. An Answer To Obesity: Weight Control Protein
5. Chronic Myelogenous Leukemia (CML) Has An Answer Now!
6. Synthetic Bone Tissue Could Be the Answer to Disfigurement Caused by Oral Cancer
7. Emotional Engagement of Husband - A Final Answer To What Women Want
8. US Preparing To Answer Japans Queries On Beef Exports
9. Running Alone Might Not Be The Answer
10. Cancer Vaccine Could Serve As an Answer to Prevent Most of the Cancer
11. Tiny Easy Fitting Pump May Be The Answer For Major Open Heart Surgery
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/23/2017)... (PRWEB) , ... May 23, 2017 , ... Therachat ... its new survey in an infographic on the current state of anxiety in support ... familiar with anxiety, was conducted in April 2017 and benchmarked general anxiety levels as ...
(Date:5/22/2017)... ... May 22, 2017 , ... Dr. Kiya Green, a ... periodontal plastic surgery treatments, including crown lengthening and gum reduction surgery, ... esthetic and functional procedures to help patients improve their oral health, reduce gummy ...
(Date:5/22/2017)... Galena, Alaska (PRWEB) , ... May 22, 2017 , ... ... town near the Arctic Circle made big headlines when it was targeted to build ... Low-Cost Energy in Bush Alaska,” former city manager Marvin L. Yoder describes the journey ...
(Date:5/21/2017)... ... , ... Chris Cornell, 52, was found dead on the night of Wednesday, May 17, 2017. ... singers in the rock industry would take his own life, but the extremely talented and ... illness played a role in the death of Chris Cornell . , Depression and ...
(Date:5/21/2017)... (PRWEB) , ... May 20, 2017 , ... Pot. Reefer. ... find it, review it, and share its attributes like never before. More than a ... to connect cannabis enthusiasts to stores, strains, products – and for the first time ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)... 22, 2017  As the specialty pharmacy industry ... to make the revolutionary shift from volume-based to ... ensuring positive patient outcomes and shaping the future ... focus away from clinical trials and toward data ... specialty drug therapy utilization in precise patient populations. ...
(Date:5/18/2017)... May 17, 2017  Bayer announced today that the ... be presented at the 53 rd Annual Meeting ... place June 2-6 in Chicago . ... span prostate, colorectal, liver and thyroid cancers, as well ... Phase II CHRONOS-1 trial of copanlisib in patients with ...
(Date:5/15/2017)... PHILADELPHIA , May 15, 2017 Enterin Inc., ... and developing novel compounds to treat Parkinson,s disease ... The study is a Phase 1/2a randomized, controlled, multicenter study ... sites. It will enroll 50 patients over a 9-to-12-month period. ... doses in 10 patients with PD. Participating sites include ...
Breaking Medicine Technology: